
Adamas Pharmaceuticals, Inc. ADMS
Country |
|
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
27.7 M |
Market Cap[1] |
$ 376 M |
EBITDA (LTM) |
$ -31.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
VBI Vaccines
VBIV
|
- | -50.87 % | $ 1.09 M | Nasdaq Capital Market | ||
|
CTI BioPharma Corp.
CTIC
|
- | - | $ 1.2 B | Nasdaq Capital Market | ||
|
Decibel Therapeutics
DBTX
|
- | - | $ 123 M | Nasdaq Global Select Market | ||
|
IVERIC bio
ISEE
|
- | - | $ 5.51 B | Nasdaq Global Select Market | ||
|
ObsEva SA
OBSV
|
- | -15.52 % | $ 10.5 M | Nasdaq Global Select Market | ||
|
Monopar Therapeutics
MNPR
|
$ 70.91 | -0.21 % | $ 526 M | Nasdaq Global Select Market | ||
|
Myovant Sciences Ltd.
MYOV
|
- | -0.04 % | $ 2.62 B | NYSE | ||
|
Poseida Therapeutics
PSTX
|
- | - | $ 857 M | Nasdaq Global Select Market | ||
|
Y-mAbs Therapeutics
YMAB
|
- | - | $ 382 M | Nasdaq Global Select Market,SPB | ||
|
Satsuma Pharmaceuticals
STSA
|
- | -0.9 % | $ 36.5 M | Nasdaq Global Market | ||
|
Anavex Life Sciences Corp.
AVXL
|
$ 0.73 | -2.01 % | $ 62.3 M | Nasdaq Capital Market | ||
|
SpringWorks Therapeutics
SWTX
|
- | - | $ 3.48 B | Nasdaq Global Select Market,SPB | ||
|
Metacrine
MTCR
|
- | - | $ 24.2 M | Nasdaq Global Select Market | ||
|
Infinity Pharmaceuticals
INFI
|
- | -46.98 % | $ 3.57 M | Nasdaq Global Select Market | ||
|
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | ||
|
Evelo Biosciences
EVLO
|
- | -14.46 % | $ 27.9 M | Nasdaq Global Select Market | ||
|
Morphic Holding
MORF
|
- | - | $ 2.42 B | Nasdaq Global Market | ||
|
Genocea Biosciences
GNCA
|
- | -15.0 % | $ 3.04 M | Nasdaq Global Select Market | ||
|
Eiger BioPharmaceuticals
EIGR
|
- | -9.21 % | $ 2.55 M | Nasdaq Global Market | ||
|
Amgen
AMGN
|
$ 444.49 | -2.93 % | $ 239 B | Nasdaq Global Select Market,SPB | ||
|
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | ||
|
Merrimack Pharmaceuticals
MACK
|
- | - | $ 216 M | Nasdaq Global Market | ||
|
Rubius Therapeutics
RUBY
|
- | -33.55 % | $ 7.81 M | Nasdaq Global Select Market | ||
|
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | ||
|
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | ||
|
vTv Therapeutics
VTVT
|
$ 16.51 | -4.51 % | $ 66.8 M | Nasdaq Global Select Market | ||
|
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market | ||
|
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | ||
|
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | ||
|
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | ||
|
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | ||
|
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market | ||
|
MediWound Ltd.
MDWD
|
$ 13.61 | -0.51 % | $ 370 M | Nasdaq Global Select Market | ||
|
Syros Pharmaceuticals
SYRS
|
- | -8.44 % | $ 3.4 M | Nasdaq Global Select Market | ||
|
NanoViricides
NNVC
|
$ 1.19 | 2.59 % | $ 24 M | NYSE American | ||
|
Gamida Cell Ltd.
GMDA
|
- | -18.25 % | $ 5.04 M | Nasdaq Global Market | ||
|
GT Biopharma
GTBP
|
$ 3.44 | 8.02 % | $ 19 M | Nasdaq Capital Market | ||
|
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | ||
|
Aldeyra Therapeutics
ALDX
|
$ 0.66 | -5.46 % | $ 39.6 M | Nasdaq Global Select Market | ||
|
AbbVie
ABBV
|
$ 286.31 | -2.22 % | $ 506 B | NYSE,SPB | ||
|
Alkermes plc
ALKS
|
$ 46.89 | 3.17 % | $ 7.72 B | Nasdaq Global Select Market | ||
|
Alnylam Pharmaceuticals
ALNY
|
$ 149.26 | -4.62 % | $ 19.6 B | Nasdaq Global Select Market,SPB | ||
|
Arcutis Biotherapeutics
ARQT
|
$ 27.59 | 0.95 % | $ 3.51 B | Nasdaq Global Select Market,SPB | ||
|
Assembly Biosciences
ASMB
|
$ 22.43 | -0.31 % | $ 251 M | Nasdaq Global Select Market,SPB | ||
|
Benitec Biopharma
BNTC
|
$ 8.2 | 0.61 % | $ 382 M | Nasdaq Capital Market | ||
|
Codexis
CDXS
|
$ 1.15 | 7.01 % | $ 100 M | Nasdaq Global Select Market | ||
|
Arrowhead Pharmaceuticals
ARWR
|
$ 43.13 | 0.33 % | $ 6.11 B | Nasdaq Global Select Market,SPB | ||
|
Compugen Ltd.
CGEN
|
$ 1.97 | -2.72 % | $ 184 M | Nasdaq Global Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.